Exercise Habits in People with Parkinson's: A Multinational Survey.

Parkinson's disease barrier exercise motivation

Journal

Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279

Informations de publication

Date de publication:
29 Aug 2024
Historique:
revised: 21 06 2024
received: 13 12 2023
accepted: 21 07 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: aheadofprint

Résumé

Exercise has been demonstrated to result in improvements in physical function, cognition, and quality of life in People with Parkinson's (PwP) but its adoption is variable. To investigate exercise preferences, levels, influencing factors among a diverse Parkinson's disease (PD) population, to understand exercise adoption patterns and plan informed interventions. A cross-sectional survey collected data through online platforms and paper-based methods. The Exercise Index (ExI) calculated exercise level based on frequency and duration. Of 2976 PwP, 40.6% exercised regularly, 38.3% occasionally, and 21.2% did not exercise. The overall mean ExI was 18.99 ± 12.37. Factors associated with high exercise levels included exercising in groups (ExI 24-26), weightlifting (ExI 27 (highest)), using muscle-building equipment (ExI 25-26), and exercising at home following an app (ExI 26). A positive trend between ExI and varied exercise groups, locations, types, and equipment was observed. No expected benefit from exercise achieved the lowest ExI (8). Having at least two exercise-promoting factors, a bachelor's degree or higher, receiving exercise advice at initial visits, and aged ≤40 years at PD onset were strong predictors of exercise (adjust OR = 7.814; 6.981; 4.170; 3.565). Falls and "other" most troublesome PD symptoms were negative predictors (aOR = 0.359; 0.466). Barriers to exercise did not predict the odds of exercise. The study shows that PwP's exercise behavior is influenced by their exercise belief, age at PD onset, doctor's advice at initial visits, education level, symptoms, and exercise-promoting factors. High exercise levels were associated with certain types of exercises and exercising in groups.

Sections du résumé

BACKGROUND BACKGROUND
Exercise has been demonstrated to result in improvements in physical function, cognition, and quality of life in People with Parkinson's (PwP) but its adoption is variable.
OBJECTIVES OBJECTIVE
To investigate exercise preferences, levels, influencing factors among a diverse Parkinson's disease (PD) population, to understand exercise adoption patterns and plan informed interventions.
METHODS METHODS
A cross-sectional survey collected data through online platforms and paper-based methods. The Exercise Index (ExI) calculated exercise level based on frequency and duration.
RESULTS RESULTS
Of 2976 PwP, 40.6% exercised regularly, 38.3% occasionally, and 21.2% did not exercise. The overall mean ExI was 18.99 ± 12.37. Factors associated with high exercise levels included exercising in groups (ExI 24-26), weightlifting (ExI 27 (highest)), using muscle-building equipment (ExI 25-26), and exercising at home following an app (ExI 26). A positive trend between ExI and varied exercise groups, locations, types, and equipment was observed. No expected benefit from exercise achieved the lowest ExI (8). Having at least two exercise-promoting factors, a bachelor's degree or higher, receiving exercise advice at initial visits, and aged ≤40 years at PD onset were strong predictors of exercise (adjust OR = 7.814; 6.981; 4.170; 3.565). Falls and "other" most troublesome PD symptoms were negative predictors (aOR = 0.359; 0.466). Barriers to exercise did not predict the odds of exercise.
CONCLUSIONS CONCLUSIONS
The study shows that PwP's exercise behavior is influenced by their exercise belief, age at PD onset, doctor's advice at initial visits, education level, symptoms, and exercise-promoting factors. High exercise levels were associated with certain types of exercises and exercising in groups.

Identifiants

pubmed: 39206964
doi: 10.1002/mdc3.14197
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
ID : RA64/044

Informations de copyright

© 2024 International Parkinson and Movement Disorder Society.

Références

Olanow W, Kieburtz K, Rascol O, et al. Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease. Mov Disord 2013;28:1064–1071.
Zhen K, Zhang S, Tao X, Li G, Lv Y, Yu L. A systematic review and meta‐analysis on effects of aerobic exercise in people with Parkinson's disease. NPJ Parkinsons Dis 2022;8:146.
Chen K, Tan Y, Lu Y, Wu J, Liu X, Zhao Y. Effect of exercise on quality of life in Parkinson's disease: a systematic review and meta‐analysis. Parkinsons Dis 2020;2020:3257623.
Mak MK, Wong‐Yu IS, Shen X, Chung CL. Long‐term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol 2017;13:689–703.
Sena IG, Costa AVD, Santos IKD, et al. Feasibility and effect of high‐intensity training on the progression of motor symptoms in adult individuals with Parkinson's disease: a systematic review and meta‐analysis. PLoS One 2023;18:e0293357.
Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology 2005;64:664–669.
Yang F, Lagerros Y, Bellocco R, et al. Physical activity and risk of Parkinson's disease in the Swedish National March Cohort. Brain 2015;138:269–275.
Crowley EK, Nolan YM, Sullivan AM. Exercise as a therapeutic intervention for motor and non‐motor symptoms in Parkinson's disease: evidence from rodent models. Prog Neurobiol 2019;172:2–22.
Johansson ME, Cameron IGM, Van der Kolk NM, et al. Aerobic exercise alters brain function and structure in Parkinson's disease: a randomized controlled trial. Ann Neurol 2022;91:203–216.
Ahlskog JE. Aerobic exercise: evidence for a direct brain effect to slow Parkinson disease progression. Mayo Clin Proc 2018;93:360–372.
Loprinzi PD, Danzl MM, Ulanowski E, Paydo C. A pilot study evaluating the association between physical activity and cognition among individuals with Parkinson's disease. Disabil Health J 2018;11:165–168.
Oguh O, Eisenstein A, Kwasny M, Simuni T. Back to the basics: regular exercise matters in parkinson's disease: results from the National Parkinson Foundation QII registry study. Parkinsonism Relat Disord 2014;20:1221–1225.
Gollan R, Ernst M, Lieker E, et al. Effects of resistance training on motor‐ and non‐motor symptoms in patients with Parkinson's disease: a systematic review and meta‐analysis. J Parkinsons Dis 2022;12:1783–1806.
Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ. Neuroprotective effects of prior limb use in 6‐hydroxydopamine‐treated rats: possible role of GDNF. J Neurochem 2003;85:299–305.
Zigmond MJ, Smeyne RJ. Exercise: is it a neuroprotective and if so, how does it work? Parkinsonism Relat Disord 2014;20(Suppl 1):S123–S127.
Hirsch MA, Iyer SS, Sanjak M. Exercise‐induced neuroplasticity in human Parkinson's disease: what is the evidence telling us? Parkinsonism Relat Disord 2016;22(Suppl 1):S78–S81.
Silveira CRA, Roy EA, Intzandt BN, Almeida QJ. Aerobic exercise is more effective than goal‐based exercise for the treatment of cognition in Parkinson's disease. Brain Cogn 2018;122:1–8.
Wu P‐L, Lee M, Huang T‐T. Effectiveness of physical activity on patients with depression and Parkinson's disease: a systematic review. PLoS One 2017;12:e0181515.
Schilling BK, Pfeiffer RF, Ledoux MS, Karlage RE, Bloomer RJ, Falvo MJ. Effects of moderate‐volume, high‐load lower‐body resistance training on strength and function in persons with Parkinson's disease: a pilot study. Parkinsons Dis 2010;2010:824734.
Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol 2013;70:183–190.
Cugusi L, Manca A, Bergamin M, di Blasio A, Monticone M, Deriu F, Mercuro G. Aquatic exercise improves motor impairments in people with Parkinson's disease, with similar or greater benefits than land‐based exercise: a systematic review. J Physiother 2019;65:65–74.
Braz de Oliveira MP, Rigo Lima C, da Silva SLA, Firmino Vaz Figueira EC, David Truax B, Smaili SM. Effect of aquatic exercise programs according to the international classification of functionality, disability and health domains in individuals with Parkinson's disease: a systematic review and meta‐analysis with GRADE quality assessment. Disabil Rehabil 2024;46:429–442.
Proud EL, Miller KJ, Morris ME, McGinley JL, Blennerhassett JM. Effects of upper limb exercise or training on hand dexterity and function in people with Parkinson disease: a systematic review and meta‐analysis. Arch Phys Med Rehabil 2023;105:1375–1387.
Patel RA, Blasucci L, Mahajan A. A pilot study of a 12‐week community‐based boxing program for Parkinson's disease. J Clin Neurosci 2023;107:64–67.
Horbinski C, Zumpf KB, McCortney K, Eoannou D. Longitudinal observational study of boxing therapy in Parkinson's disease, including adverse impacts of the COVID‐19 lockdown. BMC Neurol 2021;21:326.
Morris ME, Menz HB, McGinley JL, et al. A randomized controlled trial to reduce falls in people with Parkinson's disease. Neurorehabil Neural Repair 2015;29:777–785.
Camicioli R, Morris ME, Pieruccini‐Faria F, et al. Prevention of falls in Parkinson's disease: guidelines and gaps. Mov Disord Clin Pract 2023;10:1459–1469.
Allen NE, Canning CG, Almeida LRS, et al. Interventions for preventing falls in Parkinson's disease. Cochrane Database Syst Rev 2022;6:Cd011574.
Jin X, Wang L, Liu S, Zhu L, Loprinzi PD, Fan X. The impact of mind‐body exercises on motor function, depressive symptoms, and quality of life in Parkinson's disease: a systematic review and meta‐analysis. Int J Environ Res Public Health 2019;17:31.
Liu HH, Yeh NC, Wu YF, Yang YR, Wang RY, Cheng FY. Effects of tai chi exercise on reducing falls and improving balance performance in Parkinson's disease: a meta‐analysis. Parkinsons Dis 2019;2019:9626934.
van Nimwegen M, Speelman AD, Hofman‐van Rossum EJ, et al. Physical inactivity in Parkinson's disease. J Neurol 2011;258:2214–2221.
Mantri S, Fullard ME, Duda JE, Morley JF. Physical activity in early Parkinson disease. J Parkinsons Dis 2018;8:107–111.
Schootemeijer S, van der Kolk NM, Ellis T, et al. Barriers and motivators to engage in exercise for persons with Parkinson's disease. J Parkinsons Dis 2020;10:1293–1299.
Bouça‐Machado R, Rosário A, Caldeira D, et al. Physical activity, exercise, and physiotherapy in Parkinson's disease: defining the concepts. Mov Disord Clin Pract 2020;7:7–15.
Paul SS, Canning CG, Löfgren N, Sherrington C, Lee DC, Bampton J, Howard K. People with Parkinson's disease are more willing to do additional exercise if the exercise program has specific attributes: a discrete choice experiment. J Physiother 2021;67:49–55.
Ellis T, Boudreau JK, DeAngelis TR, et al. Barriers to exercise in people with Parkinson disease. Phys Ther 2013;93:628–636.
Lee J, Park CG, Choi M. Regular exercise and related factors in patients with Parkinson's disease: applying zero‐inflated negative binomial modeling of exercise count data. Appl Nurs Res 2016;30:164–169.
Zaman A, Ellingson L, Sunken A, Gibson E, Stegemöller EL. Determinants of exercise behaviour in persons with Parkinson's disease. Disabil Rehabil 2021;43:696–702.
Afshari M, Yang A, Bega D. Motivators and barriers to exercise in Parkinson's disease. J Parkinsons Dis 2017;7:703–711.
Putzolu M, Manzini V, Gambaro M, et al. Home‐based exercise training by using a smartphone app in patients with Parkinson's disease: a feasibility study. Front Neurol 2023;14:1205386.
Landers MR, Ellis TD. A mobile app specifically designed to facilitate exercise in Parkinson disease: single‐cohort pilot study on feasibility, safety, and signal of efficacy. JMIR Mhealth Uhealth 2020;8:e18985.
Kim A, Yun SJ, Sung KS, et al. Exercise management using a mobile app in patients with parkinsonism: prospective, open‐label, single‐arm pilot study. JMIR Mhealth Uhealth 2021;9:e27662.
Schootemeijer S, de Vries NM, Macklin EA, et al. The STEPWISE study: study protocol for a smartphone‐based exercise solution for people with Parkinson's disease (randomized controlled trial). BMC Neurol 2023;23:323.
Lützow L, Teckenburg I, Koch V, et al. The effects of an individualized smartphone‐based exercise program on self‐defined motor tasks in Parkinson's disease: a long‐term feasibility study. J Patient Rep Outcomes 2023;7:106.
Lei C, Sunzi K, Dai F, et al. Effects of virtual reality rehabilitation training on gait and balance in patients with Parkinson's disease: a systematic review. PLoS One 2019;14:e0224819.
Nuic D, van de Weijer S, Cherif S, et al. Home‐based exergaming to treat gait and balance disorders in patients with Parkinson's disease: a phase II randomized controlled trial. Eur J Neurol 2023;31:e16055.
van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR. Effectiveness of home‐based and remotely supervised aerobic exercise in Parkinson's disease: a double‐blind, randomised controlled trial. Lancet Neurol 2019;18:998–1008.
Raje P, Ning S, Branson C, Saint‐Hilaire M, de Leon MP, DePold HA. Self‐reported exercise trends in Parkinson's disease patients. Complement Ther Med 2019;42:37–41.
Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA 2018;320:2020–2028.
Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW. Correlates of physical activity: why are some people physically active and others not? Lancet 2012;380:258–271.
Leite J, Soler JMP, Horimoto A, Alvim RO, Pereira AC. Heritability and sex‐specific genetic effects of self‐reported physical activity in a Brazilian highly admixed population. Hum Hered 2019;84:151–158.
Cheval B, Tipura E, Burra N, et al. Avoiding sedentary behaviors requires more cortical resources than avoiding physical activity: an EEG study. Neuropsychologia 2018;119:68–80.
Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996–2011. Am J Prev Med 2011;41:207–215.
Kim ES, Whillans AV, Lee MT, Chen Y, VanderWeele TJ. Volunteering and subsequent health and well‐being in older adults: an outcome‐wide longitudinal approach. Am J Prev Med 2020;59:176–186.
Tsukita K, Sakamaki‐Tsukita H, Takahashi R. Long‐term effect of regular physical activity and exercise habits in patients with early Parkinson disease. Neurology 2022;98:e859–e871.
Zhang M, Li F, Wang D, Ba X, Liu Z. Exercise sustains motor function in Parkinson's disease: evidence from 109 randomized controlled trials on over 4,600 patients. Front Aging Neurosci 2023;15:1071803.

Auteurs

Priya Jagota (P)

Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Phanupong Phutrakool (P)

Chula Data Management Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Center of Excellence in Preventive & Integrative Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Nitish Kamble (N)

Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru, India.

Thuong Huyen Thi Dang (THT)

Movement Disorder Unit, Neurology Department, University Medical Center HCMC, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Zakiyah Aldaajani (Z)

Neuroscience Department, King Fahad Military Medical Complex, Dhahran, Saudi Arabia.

Taku Hatano (T)

Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.

Deva Kumar Hoskere Sreenivasa (DK)

Parkinson's Disease and Movement Disorders Clinic, Bangalore, India.

Telugu Tripura (T)

Center for Parkinson's Disease and Movement Disorders, Manipal Hospital, Bangalore, India.

Prashanth Lingappa Kukkle (PL)

Parkinson's Disease and Movement Disorders Clinic, Bangalore, India.
Center for Parkinson's Disease and Movement Disorders, Manipal Hospital, Bangalore, India.

Beomseok Jeon (B)

Department of Neurology, Seoul National University, Seoul, Republic of Korea.
Movement Disorder Center, Seoul National University Hospital, Seoul, Republic of Korea.
BJ Center for Comprehensive Parkinson Care and Rare Movement Disorders, Chung-Ang University Health Care System, Hyundae Hospital, Namyangju-si, Republic of Korea.

Noriko Nishikawa (N)

Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.

Yutaka Oji (Y)

Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.

Tai Ngoc Tran (TN)

Movement Disorder Unit, Neurology Department, University Medical Center HCMC, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Frandy Susatia (F)

Siloam Parkinson's Disease and Movement Disorders Center, Siloam Hospitals Kebon Jeruk, Jakarta, Indonesia.

Margherita Fabbri (M)

Department of Neurosciences, Clinical Investigation Center CIC 1436, Parkinson Toulouse Expert Centre, NS-Park/FCRIN Network, Toulouse, and Multiple System Atrophy Reference Centre, CHU Toulouse, Toulouse, France.

Clémence Leung (C)

Department of Neurosciences, Clinical Investigation Center CIC 1436, Parkinson Toulouse Expert Centre, NS-Park/FCRIN Network, Toulouse, and Multiple System Atrophy Reference Centre, CHU Toulouse, Toulouse, France.

Araceli Alonso Canovas (A)

Movement Disorders Unit, Hospital Ramón y Cajal, Madrid, Spain.
Medicine Department, Universidad de Alcala, Madrid, Spain.

Walaa A Kamel (WA)

Neurology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Neurology Department, Ibn-Sina Hospital, Kuwait City, Kuwait.

Pramod Kumar Pal (PK)

Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru, India.

Kempaiah Rakesh (K)

Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru, India.

Muneer Abu Snineh (M)

Department of Neurology, Hadassah Hebrew University Hospital, Jerusalem, Israel.

Parnsiri Chairangsaris (P)

Neurology Division, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

Praween Lolekha (P)

Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Roland Dominic G Jamora (RDG)

Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines.
Section of Neurology, Department of Internal Medicine, Cardinal Santos Medical Center, San Juan City, Philippines.

Norlinah Mohamed Ibrahim (N)

Neurology Unit, Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Siti Hajar Mat Desa (SHM)

Department of Nursing Services, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.

Ai Huey Tan (AH)

Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Tzi Shin Toh (TS)

Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Mona Obaid (M)

Neuroscience Department, King Fahad Medical City, Riyadh, Saudi Arabia.

Victor S C Fung (VSC)

Movement Disorder Unit, Department of Neurology, Westmead Hospital, Westmead, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Anthony Lang (A)

Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada.

Chin-Hsien Lin (CH)

Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Wafa Regragui (W)

Department of Neurology B, hôpital des Spécialités, CHU Ibn Sina, Faculté de Médecine et de Pharmacie de Rabat, Université Mohamed V, Rabat, Morocco.

Naima Bouslam (N)

Department of Neurology B, hôpital des Spécialités, CHU Ibn Sina, Faculté de Médecine et de Pharmacie de Rabat, Université Mohamed V, Rabat, Morocco.

Roongroj Bhidayasiri (R)

Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.

Classifications MeSH